Before you sell to, join or invest in Micron Biomedical, Inc.
MentionFox check on Micron Biomedical, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/micron-biomedical-inc-form-d-24000001
Check Micron Biomedical, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Micron Biomedical, Inc. filed a Form D with the Securities and Exchange Commission on 2024-12-26.
Micron Biomedical, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 26, 2024. The filing reports $15M sold. Its industry group is Biotechnology. It names Steve Damon (Chief Executive Officer), Mark Prausnitz (Director), Bas Van Buijtenen (Director) (SEC Form D, December 26, 2024).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Micron Biomedical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-12-26 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Micron Biomedical, Inc.
Free to see. No signup.
More on the people and the money behind Micron Biomedical, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Micron Biomedical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Micron Biomedical, Inc. raises, hires or launches. No email unless you switch it on.
Watch Micron Biomedical, Inc. →Get the full cited report on Micron Biomedical, Inc.
What the filing shows about Micron Biomedical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Micron Biomedical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Micron Biomedical, Inc.'s address as 575 Fourteenth Street, Nw, Suite 100, Atlanta, GA 30318.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Micron Biomedical, Inc. See pricing
Micron Biomedical, Inc. is a registered filer with the SEC (CIK 1957384) and has filed since 2022-12-07. 3 filings are on record, the latest on 2024-12-26.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Micron Biomedical, Inc.'s Form D of 2024-12-26 names Steve Damon, Mark Prausnitz, Bas Van Buijtenen and 6 more as its officers, directors or promoters.
Its new offerings report $32.01M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
A portion of the proceeds may be used for general corporate purposes, including to pay salaries to some related persons listed herein.
On the filing as: Executive Officer, Director.
Steve Damon is named as Chief Executive Officer on the Form D that Micron Biomedical, Inc. filed with the SEC on 26 December 2024, one of 9 people that filing names.
Mark Prausnitz is named as Director on the Form D that Micron Biomedical, Inc. filed with the SEC on 26 December 2024, one of 9 people that filing names.
Bas Van Buijtenen is named as Director on the Form D that Micron Biomedical, Inc. filed with the SEC on 26 December 2024, one of 9 people that filing names.
Labeeb Abboud is named as Director on the Form D that Micron Biomedical, Inc. filed with the SEC on 26 December 2024, one of 9 people that filing names.
Brian Bernick is named as Director on the Form D that Micron Biomedical, Inc. filed with the SEC on 26 December 2024, one of 9 people that filing names.
On the filing as: Executive Officer.
Henry Sebastien is named as Executive Vice President, Head of Technical Operations on the Form D that Micron Biomedical, Inc. filed with the SEC on 26 December 2024, one of 9 people that filing names.
On the filing as: Executive Officer.
Idean Marvasty is named as Chief Financial Officer on the Form D that Micron Biomedical, Inc. filed with the SEC on 26 December 2024, one of 9 people that filing names.
On the filing as: Executive Officer.
Devin McAllister is named as Executive Vice President, Chief Technology Officer on the Form D that Micron Biomedical, Inc. filed with the SEC on 26 December 2024, one of 9 people that filing names.
Matthew Goldman is named as Director on the Form D that Micron Biomedical, Inc. filed with the SEC on 26 December 2024, one of 9 people that filing names.
9 people named on the filing — 4 holding an executive role and 5 as directors only.
Named as of the 2024-12-26 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Micron Biomedical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Micron Biomedical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Micron Biomedical, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Micron Biomedical, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Micron Biomedical, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Micron Biomedical, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Atlanta
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/micron-biomedical-inc-form-d-24000001